drugset / Trial / NCT00310531
3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women
RandomizedParallel-groupDouble-blindPrevention
Summary
The aim of this trial is to investigate whether the Menostar patch is as safe and effective in the prevention of bone loss in postmenopausal women as raloxifen, a drug already registered for prevention and treatment of osteoporosis.
Timeline
- Start
- 2004-02
- Primary completion
- —
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Estradiol | Other / unclassified | 0.014 mg | Other |
| Comparator | Raloxifene | Other / unclassified | 60 mg | Oral |
Indications
No indication recorded.